Number of Patients, Male	18 (72%)
Number of Patients, Female	7 (28%)
Stage	Advanced (stage 3 or 4 at study entry)
Age	Median (range): 48 (23–68) years
Number of Prior Systemic Therapies
Patients with malignant melanoma: One regimen: two patients (33.3%). Two regimens: one patient (16.7%). Three regimens: one patient (16.7%). Four or more regimens: two patients (33.3%). Patients with nasopharyngeal carcinoma: One regimen: two patients (10.5%). Two regimens: two patients (10.5%). Three regimens: five patients (26.3%). Four or more regimens: 10 patients (52.6%).
Performance Status: ECOG	0 : 11 patients 1 : 14 patients
Other	Race: Asian, 100%. Complete baseline demographic and disease characteristics are presented in Table 2.
Cancer Types or Histologic Subtypes	Malignant melanoma, 6 (24% of patients). Nasopharyngeal carcinoma, 19 (76% of patients).